Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
25 hedge funds and large institutions have $1.62M invested in Celgene Corporation Contingent Value Rights in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more capital invested
Capital invested by funds: $1.47M → $1.62M (+$147K)
4% more funds holding
Funds holding: 24 → 25 (+1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$48.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$42.6K |
| 3 |
MSTVIM
Messner & Smith Theme Value Investment Management
San Diego,
California
|
+$19K |
| 4 |
DC
Davenport & Co
Richmond,
Virginia
|
+$3.35K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$803 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$16K |
| 2 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$4.28K |
| 3 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
-$2.24K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.74K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.55K |
CELGZ Hedge Fund Activity: Q1 2016 in Review
25 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q1 2016, worth a combined $1.62M — up 10% from $1.47M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELGZ positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was JP Morgan Private Wealth Advisors, opening a new position worth an estimated $48.1K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $16K sold.
- 25 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q1 2016, up from 24 in Q4 2015.
- Funds reported $1.62M of Celgene Corporation Contingent Value Rights stock for Q1 2016, up 10% quarter-over-quarter.
- 4 funds opened new Celgene Corporation Contingent Value Rights positions in Q1 2016 and 3 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q1 2016 was JP Morgan Private Wealth Advisors, an estimated $48.1K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q1 2016 was Virtu KCG Holdings, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2016.